Know2eat

Coenzyme Q10 (ubiquinone)

Isolated Compounds

What coenzyme q10 (ubiquinone) may help with

Ranked by how strong the human evidence is — best supported first.

Best supportedCardiovascular risk markersModerate evidence· 2 sources

Then, in order

About Coenzyme Q10 (ubiquinone)

A fat-soluble quinone made by the body and carried in every cell membrane, where it shuttles electrons in the mitochondrial respiratory chain. Supplements are almost always the oxidised form, ubiquinone, produced by yeast fermentation.

CoQ10 is one of the better-studied compounds in this category and one where the popular story and the trial record have drifted apart. The statin story is the interesting one: statins lower circulating CoQ10, which is measurable and undisputed, but randomised trials of CoQ10 for statin-associated muscle symptoms are genuinely mixed, and the largest and best-blinded ones — where patients were first shown to have symptoms that recurred on statin rechallenge — mostly found no benefit. The strongest signal is elsewhere, in chronic heart failure, where Q-SYMBIO reported fewer major adverse cardiovascular events on 300 mg daily over two years. Absorption is the limiting factor throughout: CoQ10 is a large, greasy molecule with poor and highly variable uptake, which is why formulation and food matter more here than potency on the label.

Sold as
Softgel in oil, Powder capsule, Solubilised/crystal-free softgel, Chewable tablet
Standardised to
Milligrams of ubiquinone; oil-based and solubilised formulations absorb considerably better than dry powder — a product without this marker may not resemble what was studied.
Also known as
CoQ10, Ubiquinone, Ubidecarenone, Vitamin Q10

Regulation: Sold in the US as a dietary supplement, which reaches shelves without pre-market review of efficacy or safety. Approved as a drug for mitochondrial disease in Japan, and available on prescription in some European countries.

What the research used

The amounts, forms and durations published trials of Coenzyme Q10 (ubiquinone) actually administered.

These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.

  • Studied for Chronic heart failure

    300 mg

    Moderate

    Ubiquinone, 100 mg three times daily · 2 years

    The Q-SYMBIO protocol. It is a single multicentre trial with a modest number of events, and earlier heart-failure trials using surrogate endpoints were far less consistent.

  • Studied for Statin-associated muscle symptoms

    100–200 mg

    Limited

    Softgel, daily · 4–12 weeks

    The most common trial dose, and the outcome is genuinely contested — meta-analyses split depending on which trials they include and how symptoms were confirmed.

  • Studied for Inherited mitochondrial disorders

    300–1200 mg

    Limited

    Divided doses · Months to years

    Clinical doses used under specialist supervision in rare disease, not a general supplement context. Do not read across from them.

This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.

When it was taken

Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.

Each timing below was actually compared against an alternative in a trial, which is unusual.

  • With food

    Moderate

    This one has actually been measured. CoQ10 is highly lipophilic and pharmacokinetic studies show plasma levels several-fold higher when it is taken with a fat-containing meal than fasted. Splitting larger doses across the day also raises plasma concentration more than a single dose, because absorption saturates.

    Timing was tested. A trial compared this window against another and reported a difference.

  • Split through the day

    Limited

    Doses above about 200 mg are usually divided because uptake is saturable. Heart-failure trials used three-times-daily dosing for this reason.

    Timing was tested. A trial compared this window against another and reported a difference.

The evidence in depth

Best supported: Moderate

What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.

Cardiovascular risk markers

Heart Health
Moderate evidence

In chronic heart failure, CoQ10 alongside standard care has been associated with fewer cardiovascular events and improved symptom class in randomised trials, most influentially Q-SYMBIO. The evidence base is small relative to the size of the claim, and results in populations without heart failure are much weaker.

What may be going on: CoQ10 is an obligatory electron carrier in oxidative phosphorylation, and myocardial CoQ10 content is low in failing hearts. Whether supplementation raises it enough in cardiac tissue to explain the outcomes is not settled.

Moderate evidence. Several human studies point the same way, with real caveats.

View the 2 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Healthy blood pressure

Heart Health
Limited evidence

Some meta-analyses report small reductions in systolic blood pressure, on the order of a few millimetres of mercury, but the trials are small, old and heterogeneous, and a Cochrane review concluded the evidence did not support a reliable effect.

Limited evidence. Early human work, or mostly lab and animal research.

View the 3 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Oxidative stress markers

Antioxidant & Oxidative Stress
Limited evidence

Supplementation raises plasma CoQ10 and lowers some markers of lipid oxidation in human studies. These are laboratory measures rather than health outcomes, and their clinical meaning is not established.

Limited evidence. Early human work, or mostly lab and animal research.

View the 3 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Exercise performance

Muscle & Physical Performance
Not enough evidence

There is not enough consistent human research to say CoQ10 improves exercise capacity in healthy people. Trials in athletes are small and mostly null, despite the mitochondrial rationale being intuitively appealing.

Not enough evidence. Not enough human research to say anything useful yet.

View the 3 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Things to know

Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.

  • Interaction

    Reduces the effect of warfarin

    Interacts withWarfarin and other vitamin K antagonists

    CoQ10 is structurally similar to vitamin K and case reports and small studies describe a fall in INR when it is added to warfarin, meaning less anticoagulation than intended. Anyone on warfarin who starts or stops CoQ10 needs INR monitoring around the change rather than an assumption that a supplement is neutral.

  • Interaction

    Additive with blood-pressure medication

    Interacts withAntihypertensives

    Because some trials report modest blood-pressure lowering, adding CoQ10 to antihypertensive drugs could in principle produce a larger fall than expected. The effect is small but worth mentioning to a prescriber rather than discovering it standing up.

  • Too much

    Gastrointestinal upset and insomnia at higher doses

    Nausea, appetite loss and loose stools appear at doses above roughly 200 mg, and are reduced by splitting the dose. Some people report difficulty sleeping when it is taken late in the day, which is why trials generally dose it in the morning and at midday.

  • Worth knowing

    Label milligrams do not equal absorbed milligrams

    Bioavailability differs several-fold between dry powder capsules and solubilised or oil-suspended softgels, so two products with identical labels can produce very different plasma levels. Comparing prices per milligram without accounting for formulation is close to meaningless here.

Evidence ratings on this page: 1 moderate evidence, 2 limited evidence, 1 not enough evidence.

Supplements are sold in the US without pre-market review of efficacy or safety. Nothing on this page is a recommendation to take Coenzyme Q10 (ubiquinone), or a dose to follow.